Next Quarterly Earnings
Thursday, October 29, 2026
CW 44
Pre-Market
In 63 days
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Merck & Company
Merck & Company is a leading global pharmaceutical company headquartered in the United States. The company focuses on the research, development, and delivery of innovative medicines, vaccines, and animal health products. Its aim is to improve human health worldwide through scientific advancement and novel therapies.
Recap: the latest results
Merck & Company (MRK) reported its Q2 2026 financial results before the market opened on August 4, 2026. The company reported revenue of 16607 million USD and an EPS of -0.13 USD, beating the analyst estimate of -0.27 USD by 51.9%. Following the release, the stock price reacted with a gain of +0.18%.
Generated automatically from our data — as of 08/12/2026 Read the article →
Frequently asked questions
When will Merck & Company report its next quarterly earnings?
Merck & Company is scheduled to report its next quarterly earnings on 10/29/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
When did Merck & Company last report quarterly earnings?
Merck & Company last reported quarterly earnings on 8/4/2026 (Q2 2026). Earnings per share (EPS) came in at -0.13 USD.
How does Merck & Company stock react to earnings?
Across its last 5 earnings reports, Merck & Company stock moved by ±2.7% on average the following day. The largest reaction was -9.1% on 02/04/2025; 2 of 5 reactions were positive.
How often has Merck & Company beaten expectations?
Merck & Company has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
How do I add the Merck & Company earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±2.7%
Avg. next-day move
-9.1%
Largest move (02/04/2025)
40%
Share of positive reactions
±4.2%
Avg. move after 7 days
Basis: price reactions to the last 5 report dates (close to close).
Estimates vs. results
5/5
Quarters above estimates
100%
Beat rate
+13.3%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Merck & Company
Country
🇺🇸
Index membership
More Financial Information